Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study With Retrospective and Prospective Evaluations to Determine the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disorder in Juvenile Cataract Cases in Turkey

NCT03584893 is registered in ClinicalTrials.gov with TRPHARM as lead sponsor.

NCT NCT03584893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03584893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study With Retrospective and Prospective Evaluations to Determine the Prevalence of Cerebrotendinous Xanthomatosis (CTX) Disorder in Juvenile Cataract Cases in Turkey
Lead sponsor
TRPHARM
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2018
Completion date
March 1, 2023
Enrollment
1,000 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrotendinous xanthomatosis